Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...
المؤلفون الرئيسيون: | Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
National Institute for Health Research
2016
|
مواد مشابهة
-
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
حسب: Thomas RE Barnes, وآخرون
منشور في: (2016-04-01) -
Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
حسب: Barnes, T, وآخرون
منشور في: (2017) -
Disclosing the potential impact of placebo controls in antidepressant trials
حسب: Stephanie C. Chen, وآخرون
منشور في: (2015-06-01) -
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
حسب: Thomas RE Barnes, وآخرون
منشور في: (2017-09-01) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
حسب: Crawford, A, وآخرون
منشور في: (2014)